GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Earnings Power Value (EPV)

BCAL Diagnostics (ASX:BDX) Earnings Power Value (EPV) : A$0.01 (As of Jun23)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Earnings Power Value (EPV)?

As of Jun23, BCAL Diagnostics's earnings power value is A$0.01. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.


BCAL Diagnostics Earnings Power Value (EPV) Historical Data

The historical data trend for BCAL Diagnostics's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Earnings Power Value (EPV) Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Earnings Power Value (EPV)
- -

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings Power Value (EPV) Get a 7-Day Free Trial - - - - -

Competitive Comparison of BCAL Diagnostics's Earnings Power Value (EPV)

For the Diagnostics & Research subindustry, BCAL Diagnostics's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BCAL Diagnostics's Earnings Power Value (EPV) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Earnings Power Value (EPV) falls into.



BCAL Diagnostics Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.


BCAL Diagnostics  (ASX:BDX) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.


Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.


BCAL Diagnostics Earnings Power Value (EPV) Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Earnings Power Value (EPV) provided by GuruFocus.com. Please click on the following links to see related term pages.


BCAL Diagnostics (ASX:BDX) Business Description

Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.

BCAL Diagnostics (ASX:BDX) Headlines

From GuruFocus

Q1 2023 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

BD Board Declares Dividend

By PRNewswire 01-23-2024

Q4 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Becton Dickinson and Co Earnings Call Transcript

By GuruFocus Research 01-22-2024